India’s recent Tuberculosis survey showed worse results than expected.
In high-income countries people at high risk of TB disease undergo screening programmes even when they have no symptoms.
In 2020 TB case detection fell by almost 20% and mortality rose for the first time in a decade. These setbacks are directly attributable to the COVID-19 pandemic.
Manufacturers and health systems have shown that vaccines can be quickly and effectively deployed when accompanied by keen political and financial commitments.
As a disease progresses, so too must the underlying data and reporting improve to manage the progression of the outbreak.
This challenges the current assumption that coughing is the primary driver of TB transmission.
Progress against tuberculosis has long been inadequate to reach the target of elimination by 2030. But before the COVID-19 pandemic the world was making steady progress in diagnosing and treating TB.
Smallpox, tuberculosis, measles, syphilis … a new book describes how recurring epidemics nearly wiped out Australia’s First Peoples.
COVID has shown us we can develop a range of safe and effective vaccines. Now we need to do the same for TB.
BCG remains the only widely available vaccine for TB. Yet the development of a COVID-19 vaccine over the last year shows that there is capacity to rapidly create new vaccines.
South Africa needs a public health response that expands the successes of the country’s HIV testing and treatment programme to provide care for multiple diseases.
Not achieving the targets for children and adolescents in sub-Saharan Africa means that new infections will continue to increase and HIV related mortality will be a reality for decades to come.
The key actions needed to end AIDS are relatively clear. The question is whether every government, funder, and implementing organisations will apply them.
Until vaccines that are capable of protecting all populations against TB are developed, treatment is the best option to preventing infection.
South Africa’s long-awaited TB prevalence survey results were recently released. They reveal that the country has a much higher burden of TB than previously thought.
Where there are not enough health workers to deliver medical care, one solution is to move certain tasks to less specialised health workers, a process called task-shifting.
Tuberculosis is a global threat and a public health concern on a scale similar to COVID-19.
Some insights into previous outbreaks of human coronaviruses may be useful in explaining the comparatively ‘low’ numbers of COVID-19 infections and mortality in people with HIV in South Africa.
COVID-19 has stretched South Africa’s public health services to capacity. In response, the services have increased their capacity through innovation.
The redirection of resources to COVID-19 has enormous consequences for the provision of healthcare services for other diseases, in particular, HIV programmes.